A potential explanation is chronic TCR stimulation within the tumor resulting in increased expression of activation/exhaustion markers, some of which participate in the downregulation of immune function (e.g., PD-1, CTLA-4 and TIM-3). Here, CTLA4 is linked to neoplasm.